Posted: 20 October 2026 - Uppsala, Sweden
Uppsala University is offering a postdoctoral position in Biopharmaceuticals, focusing on AAV-based therapies for Alzheimer’s and other neurodegenerative disorders. The role involves designing and producing AAV vectors and evaluating therapeutic strategies. Candidates should hold a PhD in a relevant field and have experience in molecular biology and gene therapy. The position is temporary for 2 years, starting on February 1, 2027, with applications due by November 16, 2026.